Clinic
Iom Health System LP
Iom Health System LP was paid $27.50M by Medicaid between Jan 2018 and Nov 2024, across 151 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoIOM HEALTH SYSTEM LP
FORT WAYNE, IN 46804
FORT WAYNE, IN 46804
33aNPI1306897335assigned 05/15/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$27.50M
24GClaims449,162
24DCodes billed151
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Indiana
Rank by total paid#2 of 87
Median peer was paid$115K
This provider vs. median239×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 69,779 | $1.77M | |
| 2019 | 60,662 | $2.77M | |
| 2020 | 66,720 | $3.31M | |
| 2021 | 77,036 | $5.47M | |
| 2022 | 81,866 | $6.84M | |
| 2023 | 65,898 | $5.40M | |
| 2024incomplete | 27,201 | $1.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 55,795 | 47,125 | $9.12M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 44,231 | 34,598 | $6.65M |
| 71045 | Radiologic examination, chest; single view | 6.5% | 13,465 | 10,243 | $1.79M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.9% | 1,865 | 1,340 | $1.08M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 7,363 | 6,403 | $885K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 7,111 | 5,130 | $878K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 14,835 | 10,309 | $846K |
| A0425 | Ground mileage, per statute mile | 2.8% | 9,987 | 7,783 | $776K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 1.5% | 5,561 | 4,471 | $420K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 6,156 | 5,132 | $415K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 1.3% | 3,539 | 2,757 | $359K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 1,078 | 723 | $328K |
139 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 3,513 | $296K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 8,372 | $243K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,641 | $239K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 181 | $200K |
| 16020 | <1% | 926 | $183K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 40,269 | $177K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13,507 | $176K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,901 | $166K |
| 97602 | <1% | 1,769 | $165K | |
| 80053 | Comprehensive metabolic panel | <1% | 23,181 | $138K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 154 | $138K |
| 99218 | <1% | 436 | $136K | |
| 93304 | <1% | 230 | $134K | |
| 74018 | <1% | 933 | $131K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,446 | $121K |
| 36415 | Collection of venous blood by venipuncture | <1% | 55,465 | $110K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,088 | $105K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 296 | $98K |
| 80050 | General health panel | <1% | 909 | $90K |
| 99217 | <1% | 183 | $77K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,488 | $60K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 521 | $58K |
| 99221 | <1% | 126 | $51K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 138 | $49K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 769 | $43K |
| 84484 | <1% | 7,267 | $42K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 624 | $40K |
| 87430 | <1% | 3,144 | $35K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,016 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,566 | $32K |
| G0378 | Hospital observation service, per hour | <1% | 364 | $24K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 662 | $23K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 177 | $21K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,973 | $19K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 223 | $18K |
| 81001 | <1% | 9,312 | $18K | |
| 81025 | <1% | 2,742 | $16K | |
| 83690 | <1% | 5,210 | $15K | |
| 87807 | <1% | 1,584 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,085 | $12K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 598 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 935 | $10K |
| 85027 | <1% | 5,160 | $10K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 102 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,183 | $8K |
| 0240U | <1% | 99 | $8K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 106 | $7K |
| 82728 | <1% | 593 | $7K | |
| 87428 | <1% | 208 | $6K | |
| 83735 | <1% | 2,265 | $6K | |
| 84703 | <1% | 1,106 | $5K | |
| 82947 | <1% | 4,428 | $5K | |
| 80051 | <1% | 3,039 | $5K | |
| 97803 | <1% | 48 | $5K | |
| 80061 | Lipid panel | <1% | 667 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,005 | $4K |
| 81003 | <1% | 4,499 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 147 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 147 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 147 | $4K |
| 82565 | <1% | 3,069 | $4K | |
| 82248 | <1% | 1,112 | $4K | |
| 80076 | <1% | 1,353 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 213 | $3K |
| 93321 | <1% | 392 | $3K | |
| 82247 | <1% | 964 | $3K | |
| 84520 | <1% | 3,038 | $3K | |
| 94010 | <1% | 31 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 103 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 129 | $3K |
| 84460 | <1% | 787 | $3K | |
| 84450 | <1% | 787 | $3K | |
| 84075 | <1% | 787 | $3K | |
| 88342 | <1% | 174 | $2K | |
| 86001 | <1% | 28 | $2K | |
| 85610 | <1% | 1,180 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 20 | $2K |
| 80197 | <1% | 690 | $2K | |
| 87641 | <1% | 259 | $2K | |
| 36591 | <1% | 223 | $2K | |
| 84439 | <1% | 181 | $1K | |
| 88312 | <1% | 262 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 35 | $1K |
| 85730 | <1% | 546 | $1K | |
| 99220 | <1% | 35 | $1K | |
| 82550 | <1% | 910 | $1K | |
| 83605 | <1% | 221 | $918.89 | |
| 85046 | <1% | 186 | $895.29 | |
| 82570 | <1% | 890 | $878.14 | |
| 83516 | <1% | 69 | $858.93 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 121 | $824.71 |
| 83880 | <1% | 59 | $790.18 | |
| 84550 | <1% | 840 | $695.42 | |
| 84100 | <1% | 556 | $624.87 | |
| 84156 | <1% | 890 | $619.26 | |
| 85045 | <1% | 137 | $584.84 | |
| 82607 | <1% | 73 | $557.96 | |
| 82746 | <1% | 73 | $543.90 | |
| 73630 | <1% | 12 | $512.55 | |
| 82150 | <1% | 92 | $498.30 | |
| 82330 | <1% | 77 | $407.66 | |
| 83540 | <1% | 124 | $403.08 | |
| 86255 | <1% | 30 | $389.62 | |
| 87040 | <1% | 69 | $368.42 | |
| 96376 | <1% | 91 | $294.84 | |
| 87210 | <1% | 64 | $292.03 | |
| 87799 | <1% | 14 | $285.91 | |
| 82657 | <1% | 54 | $259.44 | |
| 84481 | <1% | 13 | $229.92 | |
| 86140 | <1% | 47 | $198.68 | |
| 87081 | <1% | 31 | $192.27 | |
| 83550 | <1% | 47 | $186.20 | |
| 87070 | <1% | 41 | $168.67 | |
| 82784 | <1% | 15 | $143.91 | |
| 90744 | <1% | 179 | $110.12 | |
| 88302 | <1% | 84 | $96.90 | |
| 93325 | <1% | 392 | $84.43 | |
| 87205 | <1% | 16 | $48.42 | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,532 | $23.76 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,062 | $0.49 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 596 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 2,558 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 28 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 600 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 182 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 80 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 87 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 130 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 69 | $0.00 |
| A9270 | Non-covered item or service | 0% | 59 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 47 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 205 | $0.00 |
| 90686 | 0% | 17 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 17 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 27 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 14 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 23 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 16 | $0.00 |
| 90688 | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.